Pulsed arterial spin labeling perfusion imaging at 3 T: Estimating the number of subjects required in common designs of clinical trials

Magnetic Resonance Imaging

Volumn 29, Issue 10, 2011, Pages 1382-1389

  Murphy, Kevin ^a   Harris, Ashley D ^a   Diukova, Ana ^a   Evans, C John ^a   Lythgoe, David J ^b   Zelaya, Fernando ^b   Wise, Richard G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Arterial Spin Labelling (ASL); Clinical trial; FMRI; Pharmacological MRI; Power calculation; Sample size

Indexed keywords

ADULT; ANTERIOR CINGULATE; ARTICLE; BLOOD FLOWMETRY; BRAIN BLOOD FLOW; BRAIN PERFUSION; CONTROLLED STUDY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; INSULA; MALE; NEUROIMAGING; NORMAL HUMAN; POSTERIOR CINGULATE; PRECUNEUS; PRIMARY SOMATOSENSORY CORTEX; PRIORITY JOURNAL; PULSED ARTERIAL SPIN LABELING; REPRODUCIBILITY; SAMPLE SIZE; SECONDARY SOMATOSENSORY CORTEX; SENSITIVITY AND SPECIFICITY; THALAMUS; VISUAL CORTEX;

ADULT; BLOOD FLOW VELOCITY; CEREBROVASCULAR CIRCULATION; CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; SPIN LABELS;

EID: 82455162588     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2011.02.030     Document Type: Article

References (48)

1. Pfeuffer J., Adriany G., Shmuel A., Yacoub E., Van De Moortele P.F., Hu X., et al. Perfusion-based high-resolution functional imaging in the human brain at 7 Tesla. Magn Reson Med 2002, 47(5):903-911.
2. Kim J., Whyte J., Wang J., Rao H., Tang K.Z., Detre J.A. Continuous ASL perfusion fMRI investigation of higher cognition: quantification of tonic CBF changes during sustained attention and working memory tasks. Neuroimage 2006, 31(1):376-385.
3. Yoshiura T., Hiwatashi A., Noguchi T., Yamashita K., Ohyagi Y., Monji A., et al. Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer's disease. Eur Radiol 2009.
4. Hamandi K., Laufs H., Noth U., Carmichael D.W., Duncan J.S., Lemieux L. BOLD and perfusion changes during epileptic generalised spike wave activity. Neuroimage 2008, 39(2):608-618.
5. Sourbron S., Ingrisch M., Siefert A., Reiser M., Herrmann K. Quantification of cerebral blood flow, cerebral blood volume, and blood-brain barrier leakage with DCE-MRI. Magn Reson Med 2009, 62(1):205-217.
6. Petersen E.T., Mouridsen K., Golay X. The QUASAR reproducibility study, part II: results from a multi-center arterial spin labeling test-retest study. Neuroimage 2010, 49(1):104-113.
7. Williams D.S., Detre J.A., Leigh J.S., Koretsky A.P. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A 1992, 89(1):212-216.
8. Wong E.C., Buxton R.B., Frank L.R. Implementation of quantitative perfusion imaging techniques for functional brain mapping using pulsed arterial spin labeling. NMR Biomed 1997, 10(4-5):237-249.
9. Davis T.L., Kwong K.K., Weisskoff R.M., Rosen B.R. Calibrated functional MRI: mapping the dynamics of oxidative metabolism. PNAS 1998, 95(4):1834-1839.
10. Dai W., Garcia D., de Bazelaire C., Alsop D.C. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008, 60(6):1488-1497.
11. Wu W.C., Fernandez-Seara M., Detre J.A., Wehrli F.W., Wang J. A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med 2007, 58(5):1020-1027.
12. Iannetti G.D., Niazy R.K., Wise R.G., Jezzard P., Brooks J.C., Zambreanu L., et al. Simultaneous recording of laser-evoked brain potentials and continuous, high-field functional magnetic resonance imaging in humans. Neuroimage 2005, 28(3):708-719.
13. Biswal B., Yetkin F.Z., Haughton V.M., Hyde J.S. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 1995, 34(4):537-541.
14. Davidson R.J., Irwin W., Anderle M.J., Kalin N.H. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003, 160(1):64-75.
15. Chen Y., Parrish T.B. Caffeine dose effect on activation-induced BOLD and CBF responses. Neuroimage 2009, 46(3):577-583.
16. Wise R.G., Williams P., Tracey I. Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain. Neuropsychopharmacology 2004, 29(3):626-635.
17. Chow, Shao, Wang Sample size calculations in clinical research 2003, Taylor & Francis, New York.
18. Liu T.T., Wong E.C., Frank L.R., Buxton R.B. Analysis and design of perfusion-based event-related fMRI experiments. Neuroimage 2002, 16(1):269-282.
19. Bruns A., Kunnecke B., Risterucci C., Moreau J.L., von Kienlin M. Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats. Magn Reson Med 2009, 61(6):1451-1458.
20. Luo F., Schmidt K.F., Fox G.B., Ferris C.F. Differential responses in CBF and CBV to cocaine as measured by fMRI: implications for pharmacological MRI signals derived oxygen metabolism assessment. J Psychiatr Res 2009, 43(12):1018-1024.
21. Qiu M., Ramani R., Swetye M., Constable R.T. Spatial nonuniformity of the resting CBF and BOLD responses to sevoflurane: in vivo study of normal human subjects with magnetic resonance imaging. Hum Brain Mapp 2008, 29(12):1390-1399.
22. St Lawrence K.S., Ye F.Q., Lewis B.K., Frank J.A., McLaughlin A.C. Measuring the effects of indomethacin on changes in cerebral oxidative metabolism and cerebral blood flow during sensorimotor activation. Magn Reson Med 2003, 50(1):99-106.
23. MacIntosh B.J., Pattinson K.T., Gallichan D., Ahmad I., Miller K.L., Feinberg D.A., et al. Measuring the effects of remifentanil on cerebral blood flow and arterial arrival time using 3D GRASE MRI with pulsed arterial spin labelling. J Cereb Blood Flow Metab 2008, 28(8):1514-1522.
24. Parkes L.M., Rashid W., Chard D.T., Tofts P.S. Normal cerebral perfusion measurements using arterial spin labeling: reproducibility, stability, and age and gender effects. Magn Reson Med 2004, 51(4):736-743.
25. Aslan S., Lu H. On the sensitivity of ASL MRI in detecting regional differences in cerebral blood flow. Magn Reson Imaging 2010, 28(7):928-935.
26. Wise R.G., Rogers R., Painter D., Bantick S., Ploghaus A., Williams P., et al. Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil. Neuroimage 2002, 16(4):999-1014.
27. Mitsis G.D., Iannetti G.D., Smart T.S., Tracey I., Wise R.G. Regions of interest analysis in pharmacological fMRI: how do the definition criteria influence the inferred result?. Neuroimage 2008, 40(1):121-132.
28. Wong E.C., Buxton R.B., Frank L.R. Quantitative imaging of perfusion using a single subtraction (QUIPSS and QUIPSS II). Magn Reson Med 1998, 39(5):702-708.
29. Cox R.W. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996, 29(3):162-173.
30. Noth U., Meadows G.E., Kotajima F., Deichmann R., Corfield D.R., Turner R. Cerebral vascular response to hypercapnia: determination with perfusion MRI at 1.5 and 3.0 Tesla using a pulsed arterial spin labeling technique. J Magn Reson Imaging 2006, 24(6):1229-1235.
31. Lu H., Clingman C., Golay X., van Zijl P.C. Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn Reson Med 2004, 52(3):679-682.
32. Silvennoinen M.J., Clingman C.S., Golay X., Kauppinen R.A., van Zijl P.C. Comparison of the dependence of blood R2 and R2* on oxygen saturation at 1.5 and 4.7 Tesla. Magn Reson Med 2003, 49(1):47-60.
33. Wansapura J.P., Holland S.K., Dunn R.S., Ball W.S. NMR relaxation times in the human brain at 3.0 tesla. J Magn Reson Imaging 1999, 9(4):531-538.
34. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004, 23(Suppl 1):S208-S219.
35. Melzack R. From the gate to the neuromatrix. Pain 1999, (Suppl 6):S121-S126.
36. Shrout P.E., Fleiss J.L. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979, 86(2):420-428.
37. Jahng G.H., Song E., Zhu X.P., Matson G.B., Weiner M.W., Schuff N. Human brain: reliability and reproducibility of pulsed arterial spin-labeling perfusion MR imaging. Radiology 2005, 234(3):909-916.
38. Zar J.H. Biostatistical analysis 1999, Prentice Hall, Upper Saddle River, NJ.
39. Wang Y., Saykin A.J., Pfeuffer J., Lin C., Mosier K.M., Shen L., et al. Regional reproducibility of pulsed arterial spin labeling perfusion imaging at 3T. Neuroimage 2011, 54(2):1188-1195.
40. Owen D.G., Clarke C.F., Ganapathy S., Prato F.S., St Lawrence K.S. Using perfusion M.R.I. to measure the dynamic changes in neural activation associated with tonic muscular pain. Pain 2010, 148(3):375-386.
41. Fleisher A.S., Podraza K.M., Bangen K.J., Taylor C., Sherzai A., Sidhar K., et al. Cerebral perfusion and oxygenation differences in Alzheimer's disease risk. Neurobiol Aging 2009, 30(11):1737-1748.
42. Mozolic J.L., Hayasaka S., Laurienti P.J. A cognitive training intervention increases resting cerebral blood flow in healthy older adults. Front Hum Neurosci 2010, 4:16.
43. Brown G.G., Clark C., Liu T.T. Measurement of cerebral perfusion with arterial spin labeling: part 2. Applications. J Int Neuropsychol Soc 2007, 13(3):526-538.
44. Pattinson K.T., Rogers R., Mayhew S.D., Tracey I., Wise R.G. Pharmacological FMRI: measuring opioid effects on the BOLD response to hypercapnia. J Cereb Blood Flow Metab 2007, 27(2):414-423.
45. George E., Becerra L., Upadhyay J., Schmidt U., Borsook D. Evaluation of novel drugs using fMRI in early-phase clinical trials: safety monitoring. Drug Discov Today 2010, 15(15-16):684-689.
46. Gallichan D., Jezzard P. Variation in the shape of pulsed arterial spin labeling kinetic curves across the healthy human brain and its implications for CBF quantification. Magn Reson Med 2009, 61(3):686-695.
47. Campbell A.M., Beaulieu C. Pulsed arterial spin labeling parameter optimization for an elderly population. J Magn Reson Imaging 2006, 23(3):398-403.
48. Gunther M., Oshio K., Feinberg D.A. Single-shot 3D imaging techniques improve arterial spin labeling perfusion measurements. Magn Reson Med 2005, 54(2):491-498.